Peter A. Argenta

Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

Michael A. Bookman, Mark F. Brady, William P. McGuire et al. · Journal of Clinical Oncology · 2009 · 700 citations · Full text

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

Melissa A. Geller, Sarah Cooley, Patricia L. Judson et al. · Cytotherapy · 2010 · 426 citations · Full text

Breast Oncology, Medicine, Immunology +10

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)

David S. Miller, Virginia L. Filiaci, Robert S. Mannel et al. · Journal of Clinical Oncology · 2020 · 313 citations · Full text

Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum

Melissa S. DeRycke, Stefan E. Pambuccian, C. Blake Gilks et al. · American Journal of Clinical Pathology · 2010 · 257 citations · Full text

Tumor Biology, Oncology, Nectin 4 +13

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

John D. Andersen, Kristin L.M. Boylan, Ronald Jemmerson et al. · Journal of Ovarian Research · 2010 · 177 citations · Full text